In previous reports, among Korean patients with stage IV NSCLC, 18.1% showed brain metastasis at the time of diagnosis; this was more common in patients with a mutated EGFR (27.4%) than wild-type EGFR (14.5%)4. This evidence concerns the gene EGFR and non-small cell lung carcinoma.